Výsledky vyhledávání - "Hadeel Alabdali"

Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia

Autor: Zeyad Alzahrani, Ahmed Alhazmi, Hanan Almalki, Noura Aljehani, Mohammed Dumyati, Hadeel Alabdali

Publikováno v: Cureus. 14(12)

Tofacitinib is the first Janus kinase (JAK) inhibitor approved for treating rheumatoid arthritis (RA). Several clinical trials have evaluated the safety and effectiveness of tofacitinib in adult patients with moderately to severely active RA. Real-wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa2e81da5a5bf42a87f68c153c5cb0b
https://pubmed.ncbi.nlm.nih.gov/36620821

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání